Intravascular catheterization market seen reaching $18.83 billion by 2030

The intravascular catheterization market is projected to grow from $14.48 billion in 2026 to $18.83 billion by 2030, driven by rising demand for minimally invasive procedures, infection-resistant devices and outpatient care. North America leads now, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - The intravascular catheterization market is tied to core hospital and cardiovascular care, so growth in this category signals rising demand for procedures that deliver drugs, fluids and monitoring through blood vessels. - The market’s expansion reflects broader pressure on health systems from chronic disease, especially cardiovascular conditions, which often rely on catheter-based diagnosis and treatment.

What happened: - The Business Research Company released its Intravascular Catheterization Global Market Report 2026, covering market size, trends and forecasts through 2035. - The market is projected to rise from $13.54 billion in 2025 to $14.48 billion in 2026. - The report forecasts the market will reach $18.83 billion by 2030. - The report was published Aug. 13, 2026, from London. - Download a free sample of the report. - View the full market report.

The details: - The market is expected to grow at a 6.9% CAGR in 2026 and a 6.8% CAGR through 2030. - Historical growth was driven by greater reliance on hospital-based intravenous therapies, higher use of catheters in critical care, better catheter materials, more chronic disease cases and improved vascular access techniques. - Forecast growth is being driven by demand for minimally invasive vascular access, efforts to reduce catheter-related infections, expansion of outpatient and home healthcare, continued catheter design improvements and wider use of smart monitoring catheters. - Key trends include more use of advanced central and peripheral catheters, greater demand for infection-resistant materials, broader adoption of long-term vascular access solutions, wider use of image-guided placement and stronger focus on patient safety and comfort. - Intravascular catheterization means inserting a catheter into a blood vessel to deliver medications or fluids and to monitor health parameters. - The procedure is widely used to deliver treatment directly into the bloodstream and to assess hemodynamic conditions with minimal invasiveness. - The report identifies cardiovascular disease as a major market driver. - Cardiovascular disease includes heart disease, stroke and hypertension. - Rising obesity rates are increasing the risk of high blood pressure and diabetes, which raises the likelihood of heart problems. - Catheterization supports coronary artery disease management, angioplasty and stent placement by helping restore blood flow. - The U.S. Centers for Disease Control and Prevention reported in October 2025 that cardiovascular disease caused 919,032 deaths in the U.S. in 2023, or one in every three deaths. - The CDC also reported about 805,000 heart attacks occur annually in the U.S. - North America held the largest market share in 2025 because of established healthcare infrastructure and strong adoption of advanced medical technologies. - Asia-Pacific is expected to be the fastest-growing region during the forecast period, supported by healthcare investment, a growing patient base and more awareness of minimally invasive vascular procedures. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - New 2026 report features include market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics, key technology analysis and updated graphics and tables.

Between the lines: - The numbers point to a market that is growing steadily, not explosively, but with durable demand from both acute care and long-term disease management. - The emphasis on infection resistance, smart monitoring and image guidance suggests buyers are prioritizing safety, precision and workflow efficiency. - Regional growth is shifting toward markets with expanding healthcare investment, while North America remains the largest installed base for advanced catheter use.

What's next: - The market is expected to keep climbing through the end of the decade as minimally invasive vascular access becomes more common. - Adoption of smart monitoring catheters and long-term access devices is likely to shape product competition. - Asia-Pacific may capture a larger share of incremental growth if healthcare spending and procedure volumes continue rising.

The bottom line: - Intravascular catheterization is becoming a bigger, more technology-driven market as cardiovascular disease, infection prevention and outpatient care keep pushing demand higher.